Næste

Automatisk afspilning

Upfront Immunotherapy for Metastatic Kidney Cancer

0 Visninger • 06/26/23
Del
Indlejre
administrator
administrator
Abonnenter
0

Panelists Robert A. Figlin, MD, and Eric Jonasch, MD, provide insight on the implications of frontline trials for immunotherapy and cabozantinib use, and the rationale for combination trials for metastatic kidney cancer.

Vis mere
0 Kommentarer sort Sorter efter
Facebook kommentarer

Næste

Automatisk afspilning